Print PDF

Examining Emerging Competition Issues Involving Digital Health and Virtual Healthcare

05.24.2023 | 12 PM EDT

Digital health and virtual healthcare have both rapidly expanded in recent years and recent high profile mergers in this area have attracted antitrust scrutiny. This panel will explore recent developments in this industry, the framework for assessing transactions by healthcare and technology companies, and potential theories of competitive effects.

Hosted by the ABA's Health Care and Pharmaceuticals Committee and Mergers and Acquisitions Committee.


  • John Carroll, Sheppard Mullin
  • Emily Cotton, Analysis Group
  • Megan Browdie, Cooley LLP
  • Stephen Rodger, Federal Trade Commission

Click here for more information and to register.


Practice Areas

Jump to Page

By scrolling this page, clicking a link or continuing to browse our website, you consent to our use of cookies as described in our Cookie and Advertising Policy. If you do not wish to accept cookies from our website, or would like to stop cookies being stored on your device in the future, you can find out more and adjust your preferences here.